Publications by authors named "Sabrina Pechtel"

Claim this Profile
P
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.
Christina Rautenberg, Michael Lauseker, Jennifer Kaivers, Paul Jäger, Carolin Fischermanns, Sabrina Pechtel

Eur J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation.
Christina Rautenberg, Anika Bergmann, Sabrina Pechtel, Carolin Fischermanns, Rainer Haas

Bone Marrow Transplant· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation.
Christina Rautenberg, Anika Bergmann, Ulrich Germing, Caroline Fischermanns, Sabrina Pechtel

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS.
Christina Rautenberg, Ulrich Germing, Sabrina Pechtel, Marius Lamers, Carolin Fischermanns

Blood Cancer J· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.
Christina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, Beate Betz, Ariane Dienst

Biol Blood Marrow Transplant· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.
Fabian Zohren, Ingmar Bruns, Sabrina Pechtel, Thomas Schroeder, Roland Fenk

Blood· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Ingmar Bruns, Ulrich Steidl, Johannes C Fischer, Akos Czibere, Guido Kobbe, Sabrina Pechtel

Haematologica· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients with BCR-ABL-positive CML in chronic phase and blast crisis.
Ralf Kronenwett, Thorsten Gräf, Frank Neumann, Sabrina Pechtel, Ulrich Steidl

Leuk Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.
Ulrich Steidl, Thomas Schroeder, Christian Steidl, Guido Kobbe, Thorsten Graef, Sabrina Pechtel

Ann N Y Acad Sci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis